Skip to Content
Stock Analyst Update

Berkshire a Net Seller of Equities in Q4

While the company raised an estimated $10.6 billion during the period by selling positions in 11 different stocks, the trimming of stakes in Apple (57.2 million shares for an estimated $7.1 billion) and Wells Fargo (75.0 million shares for $2.0 billion) accounted for most of the capital raised.

Mentioned: ,

 

There were a few surprises in wide-moat Berkshire Hathaway's (BRK.B) fourth-quarter 13-F filing, with most coming as a result of actions the firm made during the third quarter following the company's amendment of its September quarter filing to note that it had acquired 58.3 million shares of Verizon (worth $3.5 billion at the end of the third quarter) 44.3 million shares of Chevron ($3.2 billion) and 3.4 million shares of Marsh & McLennan ($386 million) before the end of that period. The insurer followed those transactions during the fourth quarter with the purchase of 88.4 million shares of Verizon (for an estimated $5.2 billion), 4.2 million shares of Chevron (for $331 million) and 0.9 million shares of Marsh & McLennan (for $104 million). Berkshire also added to its stakes in Merck (6.3 million shares for an estimated $518 million), AbbVie (4.3 million for $416 million), T-Mobile (2.8 million for $352 million), Kroger (8.6 million for $281 million), Bristol-Myers Squibb (3.4 million for $206 million) and Restoration Hardware (24,200 for $10 million). 

While the company raised an estimated $10.6 billion during the period by selling positions in 11 different stocks, the trimming of stakes in Apple (57.2 million shares for an estimated $7.1 billion) and Wells Fargo (75.0 million shares for $2.0 billion) accounted for most of the capital raised. In addition to those two moves, the insurer sold 7.5 million shares of General Motors (for an estimated $267 million), 5.4 million shares of Suncor Energy (for $78 million), 0.8 million shares of US Bancorp (for $34 million) and 146,177 shares of Liberty Latin America (for $1 million). Berkshire also eliminated its stakes in M&T Bank (raising an estimated $320 million), Barrick Gold ($305 million), PNC Financial ($249 million), Pfizer ($136 million) and JPMorgan Chase ($108 million). Of interest is the fact that the firm had only recently taken stakes in Barrick Gold (in the second quarter) and Pfizer (third quarter).

 

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Greggory Warren does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.